| 1 |
|
Biological activities of quinoline derivatives |
Mini reviews in medicinal chemistry |
9 |
14 |
1648-1654 |
2009 |
Bentham Science Publishers |
| 2 |
|
Biological activities of pyrazoline derivatives-A recent development |
Recent patents on anti-infective drug discovery |
4 |
3 |
154-163 |
2009 |
Bentham Science Publishers |
| 3 |
|
Synthesis of Schiffâs bases of 8-methyl-tetrazolo [1, 5-a] quinoline as potential anti-inflammatory and antimicrobial agents |
|
|
|
|
2009 |
CSIR |
| 4 |
|
Recent Pat. Anti-Infect |
Drug Discovery |
4 |
|
154 |
2009 |
|
| 5 |
|
Structural modifications of quinoline-based antimalarial agents: Recent developments |
Journal of Pharmacy and Bioallied Sciences |
2 |
2 |
64 |
2010 |
Wolters Kluwer--Medknow Publications |
| 6 |
|
Synthesis of 6-fluoro-2-[4-formyl-3-(substituted phenyl) pyrazol-1-yl] benzothiazoles as potential antibacterial agents |
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY |
14 |
3 |
249-250 |
2005 |
CONNECT JOURNALS D-189 RAMPRATSHA, PO CHANDER NAGAR, GHAZIABAD, 201 011, INDIA |
| 7 |
|
Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives |
European journal of medicinal chemistry |
46 |
2 |
670-675 |
2011 |
Elsevier Masson |
| 8 |
|
Synthesis and pharmacological evaluation of pyrazolo [4, 3-c] cinnoline derivatives as potential anti-inflammatory and antibacterial agents |
European journal of medicinal chemistry |
57 |
|
176-184 |
2012 |
Elsevier Masson |
| 9 |
|
A review on anticancer potential of bioactive heterocycle quinoline |
European journal of medicinal chemistry |
97 |
|
871-910 |
2015 |
Elsevier Masson |
| 10 |
|
Design and synthesis of 2-chloroquinoline derivatives as non-azoles antimycotic agents |
Medicinal Chemistry Research |
20 |
|
1340-1348 |
2011 |
Springer-Verlag |
| 11 |
|
Syntheses and antiinflammatory activity of new α-pyronochalcones, α-pyronoflavones and related products from 8-acetylumbelliferone |
|
|
|
|
2001 |
NISCAIR-CSIR, India |
| 12 |
|
Synthesis and in vivo anticonvulsant evaluation of 2-chloroquinolinyl hydrazone derivatives |
Acta Pol. Pharm |
67 |
5 |
567-573 |
2010 |
|
| 13 |
|
Synthesis and antimicrobial activity of 2-chloro-6-methylquinoline hydrazone derivatives |
Journal of Pharmacy and Bioallied Sciences |
1 |
1 |
27-31 |
2009 |
Medknow |
| 14 |
|
Design, Synthesis and Screening of QuinolineâIncorporated Thiadiazole as a Potential Anticonvulsant |
Chemical Biology & Drug Design |
79 |
1 |
104-111 |
2012 |
Blackwell Publishing Ltd Oxford, UK |
| 15 |
|
One-pot synthesis of diphenyl pyrazolylmethylanilines via reductive amination using NaBH 4/I 2 and their antimicrobial screening |
Monatshefte für Chemie-Chemical Monthly |
142 |
|
637-642 |
2011 |
Springer Vienna |
| 16 |
|
Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1, 3, 4-oxadiazole and 1, 2, 4-triazolo [3, 4-b]-1, 3, 4-thiadiazole derivatives |
Journal of Enzyme Inhibition and Medicinal Chemistry |
27 |
5 |
658-665 |
2012 |
Taylor & Francis |
| 17 |
|
Design, synthesis and evaluation of novel 2-piperidinyl quinoline chalcones/amines as potential antidepressant agents |
Letters in Drug Design & Discovery |
10 |
1 |
75-85 |
2013 |
Bentham Science Publishers |
| 18 |
|
Synthesis and antimicrobial activity of 2-chloroquinoline incorporated pyrazoline derivatives |
Journal of Pharmacy And Bioallied Sciences |
1 |
1 |
32-36 |
2009 |
Medknow |
| 19 |
|
Components from seeds of Cichorium intybus Linn. |
|
|
|
|
2002 |
NISCAIR-CSIR, India |
| 20 |
|
Synthesis and Inâvitro Antimicrobial Activity of Secondary and Tertiary Amines Containing 2âChloroâ6âmethylquinoline Moiety |
Archiv der Pharmazie |
344 |
7 |
474-480 |
2011 |
WILEYâVCH Verlag Weinheim |
| 21 |
|
New 2-chloro-7-methylquinoline amine analogues as possible antimycotic agents |
Latin American Journal of Pharmacy |
29 |
|
|
2010 |
|
| 22 |
|
DNA microarray technology and drug development |
Chronicles of Young Scientists |
1 |
1 |
1-1 |
2010 |
Medknow Publications and Media Pvt. Ltd. |
| 23 |
|
N-[(2-Chloro-6-methylquinolin-3-yl) methyl] aniline |
Molbank |
2009 |
3 |
M618 |
2009 |
Molecular Diversity Preservation International |
| 24 |
|
Pyrazole incorporated 1, 2-diazanaphthalene derivatives: Synthesis and in-vivo pharmacological screening as anti-inflammatory and analgesic agents |
African Journal of Pharmacy and Pharmacology |
6 |
6 |
425-433 |
2012 |
|
| 25 |
|
Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors |
Bioorganic & Medicinal Chemistry Letters |
24 |
16 |
3986-3996 |
2014 |
Pergamon |
| 26 |
|
3-Chloro-4-fluoro-N-{[3-(4-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl] methyl} aniline |
Molbank |
2009 |
4 |
M640 |
2009 |
Molecular Diversity Preservation International |
| 27 |
|
Synthesis and biological evaluation of di-and tri-substituted imidazoles as safer anti-inflammatory-antifungal agents |
Journal of Pharmacy & Bioallied Sciences |
5 |
2 |
154 |
2013 |
Wolters Kluwer--Medknow Publications |
| 28 |
|
Career opportunities in pharmacy profession: An informative note |
Chronicles of Young Scientists |
1 |
2 |
7-7 |
2010 |
Medknow Publications and Media Pvt. Ltd. |
| 29 |
|
On the reported formation of 2-benzylchromones |
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY |
34 |
8 |
755-757 |
1995 |
NATL INST SCIENCE COMMUNICATION & INFORMATION RESOURCES-NISCAIR DR KS ⦠|
| 30 |
|
In-vitro antimicrobial screening and molecular docking studies of synthesized 2-chloro-N-(4-phenylthiazol-2-yl) acetamide derivatives. |
Drug Development & Therapeutics |
6 |
2 |
|
2015 |
|
| 31 |
|
NaBH4/I2 mediated one-pot synthesis of 4-(substituted-anilinomethyl-3-(6-methoxy-2-naphthyl)-1-phenyl-1H-pyrazoles and their antimicrobial screening |
BULGARIAN CHEMICAL COMMUNICATIONS |
47 |
2 |
502-508 |
2015 |
BULGARIAN ACAD SCIENCE CENTRAL LIBRARY 7 NOEMVRI NO 1, SOFIA, 00000, BULGARIA |
| 32 |
|
(8-Chloro-3-methyl-1H-pyrazolo [4, 3-c] cinnolin-1-yl)(pyridin-4-yl) methanone |
Molbank |
2010 |
2 |
M688 |
2010 |
Molecular Diversity Preservation International |
| 33 |
|
3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors |
Journal of Pharmacy & Bioallied Sciences |
6 |
4 |
260 |
2014 |
Wolters Kluwer--Medknow Publications |
| 34 |
|
Journal of Pharmacy and Bioallied Sciences |
Journal of Pharmacy And Bioallied Sciences |
2 |
2 |
63 |
2010 |
Wolters Kluwer--Medknow Publications |
| 35 |
|
Antimicrobial screening and one-pot synthesis of 4-(substituted-anilinomethyl)-3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives |
Journal of Pharmacy & Bioallied Sciences |
6 |
4 |
253 |
2014 |
Wolters Kluwer--Medknow Publications |
| 36 |
|
Micro RNA, A Review: Pharmacogenomic drug targets for complex diseases |
Chronicles of Young Scientists |
1 |
1 |
27-27 |
2010 |
Medknow Publications and Media Pvt. Ltd. |
| 37 |
|
Nê-{[2-(Piperidin-1-yl) quinolin-3-yl] methylene} pyridine-4-carbohydrazide |
Molbank |
2012 |
1 |
M748 |
2012 |
MDPI |
| 38 |
|
Mini review on tricyclic compounds as an inhibitor of trypanothione reductase |
Journal of pharmacy & bioallied sciences |
6 |
4 |
222 |
2014 |
Wolters Kluwer--Medknow Publications |
| 39 |
|
1-(8-Chloro-3-methyl-1 H-pyrazolo [4, 3-c] cinnolin-1-yl)-2-(2-chlorophenyl) ethanone |
Molbank |
2011 |
4 |
M744 |
2011 |
MDPI |
| 40 |
|
Synthesis and Antitubercular Screening of [(2âChloroquinolinâ3âyl) methyl] Thiocarbamide Derivatives |
Chemical Biology & Drug Design |
84 |
5 |
522-530 |
2014 |
|
| 41 |
|
Comparative atom-based 3D QSAR study of 3-nitro-1 H-1, 2, 4-triazole-based aliphatic and aromatic amines analogs for its anti-trypanosomal activities |
Medicinal Chemistry Research |
24 |
|
22-31 |
2015 |
Springer US |
| 42 |
|
In-vitro antibacterial/antifungal screening of 2-chloroquinoline scaffold derivatives |
Journal of Antibiotics Research |
1 |
1 |
101-111 |
2015 |
|
| 43 |
|
Compliance Aids: For Better Healthcare |
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES |
71 |
2 |
226-226 |
2009 |
MEDKNOW PUBLICATIONS A-108-109 KANARA BUSINESS CENTRE, GHAKTOPAR, MUMBAI ⦠|
| 44 |
|
Design, syntheses, characterization, and evaluation of 2-substituted-1, 3-bis (1-naphthylmethyl)-imidazolidine derivatives in search of safer nonsteroidal anti-inflammatory drugs. |
Drug Development & Therapeutics |
6 |
2 |
|
2015 |
|
| 45 |
|
Development of 2â(substituted benzylamino)â4âmethylâ1, 3âthiazoleâ5âcarboxylic acid derivatives as xanthine oxidase inhibitors and free radical scavengers |
Chemical Biology & Drug Design |
87 |
4 |
508-516 |
2016 |
|
| 46 |
|
Hit to lead optimization of a series of N-[4-(1, 3-benzothiazol-2-yl) phenyl] acetamides as monoacylglycerol lipase inhibitors with potential anticancer activity |
European Journal of Medicinal Chemistry |
121 |
|
318-330 |
2016 |
Elsevier Masson |
| 47 |
|
2âBenzamidoâ4âmethylthiazoleâ5âcarboxylic Acid Derivatives as Potential Xanthine Oxidase Inhibitors and Free Radical Scavengers |
Archiv der Pharmazie |
350 |
2 |
1600313 |
2017 |
|
| 48 |
|
Evaluation of 4-methyl-2-[(2-methylbenzyl) amino]-1, 3-thiazole-5-carboxylic acid against hyperglycemia, insulin sensitivity, and oxidative stress-induced inflammatory responses and β-cell damage in the pancreas of streptozotocin-induced diabetic rats |
Human & Experimental Toxicology |
37 |
2 |
163-174 |
2018 |
SAGE Publications Sage UK: London, England |
| 49 |
|
Imidazole: an essential edifice for the identification of new lead compounds and drug development |
Mini reviews in medicinal chemistry |
18 |
2 |
142-163 |
2018 |
Bentham Science Publishers |
| 50 |
|
2-[(4-Chlorobenzyl) amino]-4-methyl-1, 3-thiazole-5-carboxylic acid exhibits antidiabetic potential and raises insulin sensitivity via amelioration of oxidative enzymes and inflammatory cytokines in streptozotocinË induced diabetic rats |
Biomedicine & Pharmacotherapy |
89 |
|
651-659 |
2017 |
Elsevier Masson |
| 51 |
|
â2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acidâ a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers |
Biomedicine & Pharmacotherapy |
95 |
|
1232-1241 |
2017 |
Elsevier Masson |
| 52 |
|
Development of thiazole-5-carboxylate derivatives as selective inhibitors of monoacylglycerol lipase as target in cancer |
Mini Reviews in Medicinal Chemistry |
19 |
5 |
410-423 |
2019 |
Bentham Science Publishers |
| 53 |
|
Therapeutic potential of cinnoline core: a comprehensive review |
Mini Reviews in Medicinal Chemistry |
20 |
3 |
196-218 |
2020 |
Bentham Science Publishers |
| 54 |
|
Pyrrolidinâ2âone linked benzofused heterocycles as novel small molecule monoacylglycerol lipase inhibitors and antinociceptive agents |
Chemical Biology & Drug Design |
96 |
6 |
1418-1432 |
2020 |
|
| 55 |
|
The role of endocannabinoid pathway in the neuropathology of Alzheimerâs disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimerâs disease? |
Brain Research Bulletin |
174 |
|
305-322 |
2021 |
Elsevier |
| 56 |
|
Antidepressant potential of nitrogen-containing heterocyclic moieties: an updated review |
Journal of Pharmacy and Bioallied Sciences |
3 |
2 |
194 |
2011 |
Wolters Kluwer--Medknow Publications |
| 57 |
|
A New Pharmacological model for Hepatocellular carcinoma in Channa Punctatus and its Pharmaco networking studies |
Research Journal of Pharmacy and Technology 12(7):3559 |
12 |
7 |
3559 |
2019 |
|
| 58 |
|
Statistical and continuous manufacturing approach by design of experiment (DoE) for a robust synthetic process of a sorafenib analogue |
Research Journal of Pharmacy and Technology |
13 |
1 |
1-8 |
2020 |
A & V Publications |
| 59 |
|
Biomarkers in disease diagnosis and the role of LC-MS and NMR: A Review. |
Current Pharmaceutical Design |
|
|
|
2022 |
|
| 60 |
|
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors |
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) |
22 |
11 |
2166-2180 |
2022 |
Bentham Science Publishers |
| 61 |
|
N'-{[2-(piperidin-1-yl) quinolin-3-yl] methylene} pyridine-4-carbohydrazide |
MolBank |
2012 |
1 |
|
2012 |
MDPI Multidisciplinary Digital Publishing Institute |
| 62 |
|
Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents |
Molecules |
28 |
15 |
5860 |
2023 |
MDPI |
